Antibodies against Poly(ethylene glycol) Activate Innate Immune Cells and Induce Hypersensitivity Reactions to PEGylated Nanomedicines. [PDF]
Chen WA +5 more
europepmc +1 more source
Pre-analytic decrease of phenylalanine in plasma of patients with phenylketonuria treated with pegvaliase. [PDF]
Turgeon C +12 more
europepmc +1 more source
Therapeutic effect of histone deacetylase 6 inhibitor for a mouse model of phenylketonuria. [PDF]
Choi JE +5 more
europepmc +1 more source
Site-specific PEGylation of proteins: Insights into structural and functional changes. [PDF]
Ma M +7 more
europepmc +1 more source
Amino Acid Degrading Enzymes and Autophagy in Cancer Therapy. [PDF]
Wang Z +5 more
europepmc +1 more source
A Single-Center Genotype-Phenotype Correlation Cohort Study of Hyperphenylalaninemia Patients: Genetic Analysis as a Deterministic Tool for Treatment Consistency. [PDF]
Peker A +6 more
europepmc +1 more source
Advancing Gene Therapy for Phenylketonuria: From Precision Editing to Clinical Translation. [PDF]
Yu I, Jeong J.
europepmc +1 more source
Regulatory framework for polymer-based nanotherapeutics in clinical translation. [PDF]
Stucchi F +3 more
europepmc +1 more source
Homocystinuria: Advances in metabolic and molecular therapies targeting homocysteine pathways (Review). [PDF]
Althubity AA.
europepmc +1 more source
Arginine Transporters in Human Cancers: Emerging Mechanisms and Clinical Implications. [PDF]
Cai X, Shang L, Li Y, Cao Y, Shi F.
europepmc +1 more source

